Clare T.D. and Chairman of the Joint Oireachtas Committee on Foreign Affairs and Trade Pat Breen today met with the new UL Hospitals Group CEO Colette Cowan to discuss concerns regarding the provision of warfarin services in Kilrush.
Deputy Breen had sought a Meeting with the CEO of the UL Hospital Group following concerns that those patients who currently attend the Kilrush Warfarin Clinic and whom would not be deemed suitable for the new oral anticoagulants (NOACs) which have emerged as an alternative to warfarin would be required to travel into Ennis to be accommodated in the future.
Speaking following the Meeting, Deputy Breen said that he had a very constructive Meeting with the UL Hospital Group’s CEO Colette Cowan. “I raised the issues of concern for warfarin patients who are currently attending the Clinic in Kilrush. I pointed out the additional cost that these patients who would not be deemed suitable for the new NOAC’s would incur if they had to travel into Ennis and I urged the CEO to find a resolution for those patients requiring on going treatment to be accommodated in Kilrush.”
“CEO Colette Cowan assured me that she would take my concerns on board. She advised me that the HSE is currently in discussions with GP’s regarding a number of issues and that the warfarin services in Kilrush will feature in these discussions. She is very aware of the concerns, the logistical problems which it could cause for patients who would require ongoing treatment and is hoping that a successful resolution and agreement can be reached with the GP’s to accommodate those patients locally.
Following our Meeting, she is to revert back to me at the earliest opportunity.